The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Schilsky, Richard
Item TypeName
Concept Drug Evaluation
Academic Article Antifolates: the next generation.
Academic Article Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.
Academic Article Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.
Academic Article Platinum-based combination chemotherapy in advanced non-small cell lung cancer: a randomized phase II trial of the Cancer and Leukemia Group B.
Academic Article Drug safety and drug efficacy: two sides of the same coin.
Academic Article Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.
Academic Article Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.
Academic Article Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.
Academic Article Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
Academic Article Cytarabine-cis-platin interactions in patients with advanced cancer.
Academic Article Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
Academic Article Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial.
Academic Article Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
Academic Article Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
Academic Article Limited sampling models for amonafide (NSC 308847) pharmacokinetics.
Academic Article Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641.
Academic Article A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients.
Academic Article Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Search Criteria
  • Drug Evaluation